Moderna stock tumbles despite positive melanoma vaccine trial results The Crypto Basic 2h The Crypto Basic 2h Moderna Merck and Co Pharma All sources
Moderna stock crashes 25%, loses about $24 billion after cancer vaccine data leak The Economic Times 16h The Economic Times 16h Moderna Merck and Co Pharma All sources
Moderna stock plummets after reported leak of disappointing cancer-vaccine data Just The News 12h Just The News 12h Moderna Biotechnology Politics All sources
Merck and Moderna Prepare FDA Filing for Personalized mRNA Melanoma Vaccine Paired with Keytruda After Phase 3 Results Medical Daily 3d Medical Daily 3d mRNA Moderna Cancer
Moderna stock jumps 7% near 52-week high ahead of NASDAQ-100 Entry The Crypto Basic 13:37 Tue, 06 Oct The Crypto Basic 13:37 Tue, 06 Oct Moderna Nasdaq Pakistani Economy
Moderna stock plummets even after data confirm cancer vaccine with Merck met key endpoints in melanoma trial Boston Globe 11:38 Article paywall
Merck, Moderna Personalized mRNA Caner Vaccine Cuts Melanoma Recurrence Risk In Phase 3 Study RTT News 06:53